P. Mitkowski
11 Papers
54 Citations
P. Mitkowski is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Pathways for training and accreditation for transvenous lead extraction: a European Heart Rhythm Association position paper
Jean-Claude Deharo,Maria Grazia Bongiorni,A. Rozkovec,Frank A. Bracke,Pascal Defaye,I. Fernandez-Lozano,P. G. Golzio,Bert Hansky,Charles Kennergren,Antonis S. Manolis,P. Mitkowski,E. S. Platou,Charles J. Love,Bruce L. Wilkoff +13 more
TL;DR: The present document focuses on the rising burden and the increasing complexity of techniques of lead extraction with an emphasis on the critical issues of training, accreditation, and documentation of results.
212
'Pathways for training and accreditation for transvenous lead extraction: a European Heart Rhythm Association position paper' [Europace 2012;14:124-134. doi: 10.1093/europace/eur338]
European Heart Rhythm Association. Pathways for training and accreditation for transvenous lead extraction: A European Heart Rhythm Association position paper
Jean Claude Deharo,B. Wilkoff,Maria Grazia Bongiorni,A. Rozkovec,Frank A. Bracke,Pascal Defaye,I. Fernandez Lozano,P. G. Golzio,Bert Hansky,Charles Kennergren,Antonis S. Manolis,P. Mitkowski,Charles J. Love,E. S. Platou +13 more
- 01 Jan 2012
TL;DR: The European Heart Rhythm Association charged the present writing committee with the task of producing a consensus document on training and accreditation for transvenous extraction of chronically implanted pacing and defibrillator leads as mentioned in this paper.
20
Which patients at risk of cardiovascular disease might benefit the most from inclisiran? Polish experts’ opinion. The compromise between EBM and possibilities in healthcare
Maciej Banach,Jarosław Kaźmierczak,P. Mitkowski,Krystian Wita,Marlena Broncel,Mariusz Gąsior,Marek Gierlotka,R. Gil,Piotr Jankowski,Maciej Niewada,Adam Witkowski +10 more
TL;DR: The fastest way to have inclisiran available for the polish patients, with the necessary changes of the existing drug program for PCSK9 inhibitors (B-101), is indicated, explaining why it is the optimal way, and why, taking into account available EBM data (the ORION program), inclisIRan should be added to this program.
Short- and Long-Term Outcomes of Left Main Coronary Artery Stenting in Patients Disqualified from Coronary Artery Bypass Graft Surgery
Marta Kałużna-Oleksy,Maciej Lesiak,Aleksander Araszkiewicz,Stefan Grajek,P. Mitkowski,Małgorzata Pyda,Marek Grygier +6 more
TL;DR: LM PCI in patients disqualified from CABG is an effective and safe procedure with a low in-hospital complication rate and long-term results are satisfactory.
4